Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Mirtazapine may cause hair loss and change hair color, but stopping the drug can reverse these effects.

Ivermectin effectively treats mange in rabbits.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Fipronil spray effectively treats ear mites in Persian cats.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Tioconazole cream is highly effective and easy to use for treating sheep dermatophytosis.

The lotion with menthol promotes more hair growth than the one without menthol.

Blood tests confirmed a baby in the womb had a CMV infection.

The herbal mix of hibiscus and vitex shows promise for treating autoimmune diseases due to its effectiveness and low toxicity.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

N-acetylcysteine improved symptoms of trichotillomania and bulimia.

Fludalanine failed as an effective oral antibiotic despite efforts.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

The G allele of IFITM3 rs12252 is linked to more severe COVID-19.

Methotrexate plus prednisolone had the fewest serious side effects.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Kolaviron and quercetin may help treat prostate issues.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.